| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 03/03/2015 | US8969320 Hyaluronic acid derivatives containing groups able to release NO |
| 03/03/2015 | US8969317 MicroRNA compounds and methods for modulating miR-21 activity |
| 03/03/2015 | US8969308 Treatment of T-cell mediated diseases |
| 03/03/2015 | US8969299 Therapeutic agents for regulating serum phosphorus |
| 03/03/2015 | US8969292 High affinity leptins and leptin antagonists |
| 03/03/2015 | US8968996 Compositions and methods for rapid immunization against dengue virus |
| 03/03/2015 | US8968794 Antiseptic compositions and uses thereof |
| 03/03/2015 | US8968793 Antiseptic compositions and uses thereof |
| 03/03/2015 | US8968791 Dietary supplements for promotion of growth, repair, and maintenance of bone and joints |
| 03/03/2015 | US8968782 Combination degradable and non-degradable matrices for active agent delivery |
| 03/03/2015 | US8968768 Phytosterol nutritional supplements |
| 03/03/2015 | US8968762 Implant for tissue repair including chitosan |
| 03/03/2015 | US8968755 Topical base and active agent-containing compositions, and methods for improving and treating skin |
| 03/03/2015 | US8968746 Complexation of nucleic acids with disulfide-crosslinked cationic components for transfection and immunostimulation |
| 03/03/2015 | US8968744 Aqueous composition comprising a biological antigen and an acrylic acid polymer |
| 03/03/2015 | US8968742 Antibody drug conjugates (ADC) that bind to 158P1D7 proteins |
| 03/03/2015 | US8968741 Anti-CD22 antibodies and immunoconjugates and methods of use |
| 03/03/2015 | US8968736 Human antibodies to GFRα3 and methods of use thereof |
| 03/03/2015 | US8968731 Treatment of uveitis |
| 03/03/2015 | US8968726 Lactoferrin and angiogenin compositions and uses thereof |
| 03/03/2015 | US8968702 Inhibition of HIF-1 activation for anti-tumor and anti-inflammatory responses |
| 02/26/2015 | WO2015026818A1 Survival benefit in patients with solid tumors with elevated c-reactive protein levels |
| 02/26/2015 | WO2015026601A2 Dithiol mucolytic agents |
| 02/26/2015 | WO2015025871A1 Methods for evaluating and screening s1p1 receptor agonists |
| 02/26/2015 | WO2015025770A1 Method for screening pain inhibitor and medicinal composition for preventing or treating pain |
| 02/26/2015 | WO2015025259A1 Indole-3-aldehyde for treating dysreactive immune disorders |
| 02/26/2015 | WO2015024925A1 Modulators of the unconventional secretory pathway for use in the treatment of alexander disease |
| 02/26/2015 | US20150057361 Anti-metastatic agents predicated upon polyamine macrocyclic conjugates |
| 02/26/2015 | US20150057357 Bis (thiohydrazide amide) compounds for treating cancers |
| 02/26/2015 | US20150057343 AGONISTS OF THE AhR RECEPTOR PATHWAY HAVING SEBOSUPPRESSIVE ACTIVITY AND A METHOD FOR IDENTIFYING SAID AGONISTS |
| 02/26/2015 | US20150057325 Compounds capable of modulating/preserving endothelial integrity for use in prevention or treatment of acute traumatic coagulopathy and resuscitated cardiac arrest |
| 02/26/2015 | US20150057312 Substituted quinolines as bruton's tyrosine kinases inhibitors |
| 02/26/2015 | US20150057309 Novel 3,5-disubstituted-3h-imidazo[4,5-b]pyridine and 3,5- disubstituted -3h-[1,2,3]triazolo[4,5-b] pyridine compounds as modulators of c-met protein, etc |
| 02/26/2015 | US20150057308 Fluorinated 3-(2-Oxo-3-(3-Arylpropyl)Imidazolidin-1-yl)-3-Arylpropanoic Acid Derivatives |
| 02/26/2015 | US20150057303 Synthesis of (r)-n-methylnaltrexone |
| 02/26/2015 | US20150057302 Spiroindoline compounds for use as anthelminthics |
| 02/26/2015 | US20150057293 New compounds |
| 02/26/2015 | US20150057290 Method of using flibanserin for neuroprotection |
| 02/26/2015 | US20150057277 Certain chemical entities, compositions, and methods |
| 02/26/2015 | US20150057266 Pharmaceutical Composition Having Improved Dissolution Profiles For Poorly Soluble Drugs |
| 02/26/2015 | US20150057259 Stabilized compositions containing alkaline labile drugs |
| 02/26/2015 | US20150057257 Isoxazolidine derivatives |
| 02/26/2015 | US20150057256 Novel polymorphic crystal forms of 5-(2--1-(r)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one, heminapadisytlate as agonist of the beta2 adrenergic receptor |
| 02/26/2015 | US20150057255 Use of nk-1 receptor antagonists in pruritus |
| 02/26/2015 | US20150057250 Inhibitors of osteoclast activity for treating arthritis |
| 02/26/2015 | US20150057246 Silyl-containing heterocyclic compounds and methods of use thereof for the treatment of viral diseases |
| 02/26/2015 | US20150057245 Use of lipid conjugates in the treatment of inflammatory disorders |
| 02/26/2015 | US20150057239 Solid oral pharmaceutical compositions for isoxazoline compounds |
| 02/26/2015 | US20150057227 Compositions, devices and methods of use thereof for the treatment of cancers |
| 02/26/2015 | US20150057220 Fused aromatic phosphonate derivatives as precursors to ptp-1b inhibitors |
| 02/26/2015 | US20150056308 Intranasal administration of ketamine to treat depression |
| 02/26/2015 | US20150056305 Dithiol mucolytic agents |
| 02/26/2015 | US20150056298 Hepatic neuromodulation using fluids or chemical agents |
| 02/26/2015 | US20150056274 Compositions, methods and kits for reducing lipid levels |
| 02/26/2015 | US20150056267 Angiogenesis inhibitors |
| 02/26/2015 | US20150056262 Solid forms for tissue repair |
| 02/26/2015 | US20150056253 Engineered nucleic acids and methods of use thereof |
| 02/26/2015 | US20150056233 Influenza hemagglutinin proteins and methods of use thereof |
| 02/26/2015 | US20150056224 Compositions and methods for activating stimulator of interferon gene-dependent signalling |
| 02/26/2015 | US20150056219 Methods and compositions for cancer therapy using mutant light molecules with increased affinity to receptors |
| 02/26/2015 | US20150056213 Selective histone deactylase 6 inhibitors |
| 02/26/2015 | US20150056207 Combination therapy with c-met and egfr antagonists |
| 02/26/2015 | US20150056195 Compositions and methods for inihibiting tumorigenicity of senescent cancer cells induced by chemotherapy |
| 02/26/2015 | US20150056194 Modified green tea polyphenols and methods thereof for treating liver disease |
| 02/26/2015 | US20150056192 Novel compositions of combinations of non-covalent dna binding agents and anti-cancer and/or anti-inflammatory agents and their use in disease treatment |
| 02/26/2015 | US20150056189 Cdr-modified anti-siglec-15 antibody |
| 02/26/2015 | US20150056186 Combination therapy of a type ii anti-cd20 antibody with an anti-bcl-2 active agent |
| 02/26/2015 | US20150056176 Anti-inflammatory composition |
| 02/26/2015 | US20150056172 Methods and compositions using fgf-8 to enhance cardiac regeneration and attenuate adverse cardiac remodeling |
| 02/26/2015 | US20150056168 Bacterial expression system |
| 02/26/2015 | US20150056167 Peptides, derivatives and analogs thereof, and methods of using same |
| 02/26/2015 | US20150056165 Novel cyclosporin analogues for preventing or treating hepatitis c infection |
| 02/26/2015 | US20150056164 Antiviral Compounds and Uses Thereof |
| 02/26/2015 | US20150056163 Leukotoxin e/d as a new anti-inflammatory agent and microbicide |
| 02/26/2015 | US20150056161 Regeneration of endogenous myocardial tissue |
| 02/26/2015 | US20150056160 Chemically induced intracellular hyperthermia |
| 02/26/2015 | US20150056149 Topical tetracycline compositions |
| 02/26/2015 | US20150056135 Treatment of Proliferative Disorders Using Antibodies to PSMA |
| 02/26/2015 | US20150056134 Nucleic Acids Encoding Human Antibodies To Sialyl-Lewis A |
| 02/25/2015 | EP2839837A1 Oncolytic Farmington rhabdovirus |
| 02/25/2015 | EP2839831A1 Modulators of the unconventional secretory pathway for use in the treatment of Alexander disease |
| 02/25/2015 | EP2839830A1 Kits and compositions for treating lower urinary tract disorders |
| 02/25/2015 | EP2838536A1 Immediate release pharmaceutical compositions with abuse deterrent properties |
| 02/25/2015 | EP2838517A1 Orally available pharmaceutical formulation suitable for improved management of movement disorders |
| 02/25/2015 | EP2838516A1 Immediate release, abuse deterrent pharmaceutical compositions |
| 02/25/2015 | EP2838509A1 Formulations and methods for treatment of inflammatory skin diseases |
| 02/25/2015 | EP2838508A1 Formulations and methods for treatment of acne and inflammatory skin conditions |
| 02/25/2015 | EP2838505A1 Combination of a non-steroidal anti-inflammatory drug with an anti-histaminic drug intended for ophthalmic use |
| 02/24/2015 | US8962924 Composition and method to alleviate joint pain |
| 02/24/2015 | US8962844 1,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors |
| 02/24/2015 | US8962843 1,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors |
| 02/24/2015 | US8962831 Tyrosine kinase inhibitors |
| 02/24/2015 | US8962810 Macrocyclic heterocyclic compound for inhibiting hepatitis C virus and preparation and use thereof |
| 02/24/2015 | US8962686 Method and medication for prevention and treatment of ocular hypertension and glaucoma |
| 02/24/2015 | US8962684 Antioxidant composition |
| 02/24/2015 | US8962681 Use of aminoacetonitrile derivatives against endoparasites |
| 02/24/2015 | US8962670 Anti-cancer agents |
| 02/24/2015 | US8962667 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
| 02/24/2015 | US8962660 Oxabicyclo [2.2.2] acid GPR120 modulators |
| 02/24/2015 | US8962659 Phenoxyethyl piperidine compounds |